s6y
Company name or ticker
Search
Martin Daniel C.
4
Deciphera Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
Filed
Tuesday, June 21, 2022
Period
Jun 16, 2022
Accession number
0001209191-22-038428
Documents
FORM 4 SUBMISSION
4
On sec.gov
Filing index
All files
Complete submission text
SGML header